After a heated run beyond the $40 mark, this biotech stock has taken a hard fall over the past 7 weeks. Yet nothing significant has happened to its intriguing pipeline. The share price and expectation have reset and it's time to consider buying some shares. Read More
Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.
Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.
Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.
The emergence of social media has changed the world, and it has opened up some tantalizing new investment opportunities for investors. However, before buying into the hype, it's important to keep in mind that ultimately Wall Street will demand to see growth and profits. Read More
Several weeks ago we looked at United Continental Holdings (NYSE: UAL), whose business seemed immune to bad publicity. This week we review the case of Chipotle (NYSE: CMG) to see whether the restaurant chain will likely recover from the latest health scare. Read More